Measurement of the Optic Nerve Sheath Diameter
Microconvex Probe Versus Linear Probe for Measurement of the Optic Nerve Sheath Diameter
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is a prospective assessment of the accuracy of ocular ultrasound as a tool to measure the diameter of the optic nerve sheath and the eyeball transverse diameter in healthy adult patients presenting to the Emergency Department and have confirmatory imaging of the optic nerve as part of their clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 8, 2023
August 1, 2023
2.2 years
July 1, 2022
August 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Primary objective is to determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the optic nerve sheath diameter compared to CT measurements.
The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done.
through study duration, one year is anticipated.
Secondary Outcomes (3)
To determine the level of intra- and inter-rater variability for ultrasound measurement of the optic nerve sheath diameter between the two transducer types.
through study duration, one year is anticipated.
To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the eyeball transverse diameter compared to CT measurements.
through study duration, one year is anticipated.
To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the ONSD/ETD compared to CT measurements.
through study duration, one year is anticipated.
Study Arms (1)
Ocular Ultrasound
OTHERThis arm includes all patients enrolled who will have an ocular ultrasound with two different probes for a total of four ultrasounds.
Interventions
1\. Patients presenting to the emergency department and have a normal head and/or ocular computed tomography scan will be considered for inclusion in this study. Study staff will discuss the study with the patient and obtain consent. At that point, operator will perform ocular ultrasound. Procedure will start with either the linear or microconvex probe. A single-use sterile gel packet will be used to apply gel to one closed eyelid. The probe will be placed with minimal pressure on the eye. A transverse measurement of the ONSD will be taken. In this same view the maximal transverse diameter of the eyeball will also be measured. Images of the eye with ONSD and ETD measurements will be captured. Repeat until three measurements have been obtained resulting in an average ONSD and ETD for that eye. Repeat for other eye. Switch probe and repeat on both eyes.
Eligibility Criteria
You may qualify if:
- years of age and older, and;
- Present to Cleveland Clinic Akron General's ED (Main)
- Have CT head and/or ocular ordered as a part of clinical care that is read as normal or no acute disease (confirmatory imaging), and;
- Agree to and provide written consent for participation.
You may not qualify if:
- Acute ocular pathology
- Abnormal brain and/or ocular CT
- History of increased intracranial pressure or optic nerve disease
- Not medically stable
- Pregnant or incarcerated
- Unable to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Akron General
Akron, Ohio, 44307, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua Jacquet, MD
Cleveland Clinic Akron General
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No masking. All subjects have same intervention.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician
Study Record Dates
First Submitted
July 1, 2022
First Posted
September 21, 2022
Study Start
October 1, 2022
Primary Completion
December 30, 2024
Study Completion
December 31, 2024
Last Updated
August 8, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share